Make it an Annual Event

San Francisco - A baseline examination followed by yearly screening for retinopathy is probably adequate for patients taking chronic antimalarial therapy, Stephen E. Wolverton, M.D., said.

Related Videos
Related Content

Treating the Chest with Care on a Transgender Patient

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Isotretinoin Best Practices: New Formulations, Avoiding Relapses, and More

March 20th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Raj Chovatiya, MD, PhD, Discusses All Things Inflammatory Diseases at AAD 2023

March 20th 2023

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

Treating the Chest with Care on a Transgender Patient

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Isotretinoin Best Practices: New Formulations, Avoiding Relapses, and More

March 20th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Raj Chovatiya, MD, PhD, Discusses All Things Inflammatory Diseases at AAD 2023

March 20th 2023

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023

Treating the Chest with Care on a Transgender Patient

March 20th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

Isotretinoin Best Practices: New Formulations, Avoiding Relapses, and More

March 20th 2023

The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice

December 2nd 2021

Raj Chovatiya, MD, PhD, Discusses All Things Inflammatory Diseases at AAD 2023

March 20th 2023

Establishing a Culture of Respect: Responding to Patient-Initiated Harassment

March 20th 2023
© 2023 MJH Life Sciences

All rights reserved.